Abstract. The use of reversing agents to overcome drug resistance is a potential new treatment strategy for both malaria and cancer. Laboratory studies have raised questions about the safety of this therapeutic approach, but data in humans are lacking. We therefore assessed the toxic potential of reversing agent therapy in Thai patients receiving quinine (17 mg/kg given over 4.5 hr) for falciparum malaria by serial measurements of the QT, interval, an electrocardiographic (ECG) marker of the effect of quinine. Six patients were randomly assigned to receive intravenous quinine alone while another six received one intramuscular injection of 12.5 mg of the reversing agent prochlorperazine (PC; compazine®, stemetil®) 2.5 hr after the quinine infusion had begun. Compared with baseline values at 2.5 hr, there was prolongation of the QTc interval 30, 60, 90, and 120 min after PC was injected (P < 0.05) but no further lengthening with quinine alone (P > 0.2). Prochlorperazine alone did not lengthen the QT, interval in six healthy volunteers. Neither total nor free quinine plasma levels increased after PC was injected, suggesting that ECG changes may have been due to PC-induced intracellular accumulation of quinine. Although only minor quinine ECG effects were amplified by the reversing agent PC in this study, resistance-reversing therapy could potentiate more serious drug effects. The possibility that more serious toxic effects could be produced by this therapeutic approach should be investigated further.
Infection with drug-resistant strains of Plas-intracellular concentrations of chloroquine in modium falciparum is a growing public health cultured hepatocytes. 6 It has also been observed problem in most malaria-endemic areas. Mech-that when mice were given the anticancer comanisms of resistance remain poorly understood, pound vincristine with the reversi ig agent verbut some resistant parasites can rapidly release apamil, vincristine tissue levels were increased, antimalarial compounds, thereby reducing drug with more deaths following the combination than accumulation.' Greater drug efflux is one of sev-in mice given vincristine alone.' eral features resistant malaria parasites share with
We therefore investigated the possible toxicity drug-resistant cancer cells, in which the efflux is of reversing agent treatment by measuring delays mediated by a transport protein, P-glycopro-in myocardial repolarization in patients receivtein.-I ing quinine for falciparum malaria. Such delays, A new, as yet unproven approach to malaria manifested as a prolonged QT, interval on the treatment involves reversing resistance by using electrocardiogram (ECG), occur commonly at calcium antagonists and other reversing agents therapeutic plasma quinine levels but are not to inhibit the parasite's drug efflux pump." How-associated with cardiac or other serious adverse ever, the rationale for reversing agent therapy is effects.8-,o A prolongation of the QTc interval is perhaps compromised by the fact that normal therefore an objective, safe measure of quinine human tissues contain P-glycoprotein," 5 which effect. Serial QT, interval determinations were may pump harmful substances out of cells. If so, made in patients receiving quinine alone and a reversing agent could concentrate a co-admin-compared with values obtained in patients reistered antimalarial drug not only within the par-ceiving a combination of quinine and prochlorasite but also within normal host tissue. For ex-perazine (PC; compazineg, stemetil® were calculated in all cases. were entered into the study after giving written informed consent. Prospective patients who by RESULTS history were likely to have taken antimalarials that would still be present in the blood were ex-
The initial mean ± SD falciparum parasitemia cluded. Study subjects were randomly assigned was 16,413 + 4,423/mm 3 ofblood in the Q group to receive one of two regimens by a computer-and 16,637 ± 4,487 in the QP group (P > 0.1). generated random numbers list. The first regi-There were no significant differences between men (Q) was a constant rate infusion of quinine treatment groups in the initial QT, interval, age, dihydrochloride given as 7 mg/kg of body weight body weight, or hematologic indices. Biochemfor 30 min followed by 10 mg/kg for 4 hr. ' 2 The ical parameters were also comparable except that second regimen (QP) included an identical inmean serum albumin levels were higher in the fusion of intravenous quinine but, in addition, Q group than in the QP group (4.4 ± 0.1 and 12.5 mg of PC was given intramuscularly 2.5 hr 3.9 ± 0.1 g/dl, respectively; P < 0.05). Individafter the quinine infusion had begun. A control ual albumin levels, however, were all within the group of healthy Thai male volunteers received normal range. a single intramuscular injection of 12.5 mg of PC The QT, interval increased to a median of 106% alone.
of the preinfusion value 2.5 hr after beginning Prninfusion ECGs were performed and retreatment with quinine (range 103-111%). At 2.5 peated at 30-min intervals. The QT, interval was hr, half the malaria patients received intramusmeasured without knowledge of the patient's drug cular PC and half did not; the quinine infusion regimen from the lead showing greatest T-U dis-was continued in both groups. Compared with tinction at a paper speed of 50 mm/sec. The QT, baseline values at 2.5 hr, there was statistically intervals were corrected for rate' 3 and the mean significant further QT. prolongation 30, 60, 90, of five measurements was recorded. Patients were and 120 nin after injection of PC in the QP group questioned every hour about quinine side effects. The prolongations of myocardial repolarizabound) quinine was determined by ultrafiltration tion in the QP group could not be explained by using a micropartition system with YMT mem-a PC-quinine interaction that affected either total branes (Amicon Division, Beverly, MA). Plasma or free quinine plasma levels (Figures Ib and c , and ultrafiltrate samples were assayed for quirespectively). The concentration-time curves for nine by high-performance liquid chromatogra-total and free quinine in the QP patients were phy (H PLC) using fluorescence detection.' 4 Plas-similar to those in the Q group, and quinine conma specimens for PC analysis detection were centration curves differed from the QTc curves taken every half-hour for 2 hr after the drug was (Figure 1) . Similarly, plasma levels of PC did not given, protected from light, and stored at -709C. correlate with QT, intervals during the 2-hr peThe PC levels were measured by HPLC with riod following injection of PC (P > 0.2; Table electrochemical detection.' " 1).
Clinical and laboratory findings on admission
No cardiovascular or other side effects ocwere compared using the Student's i-test for nor-curred in either the 12 malaria patients or the 
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FIGURE 1. a, Changes in the QT, interval after treatment with either quinine and prochlorperazine (group QP). quinine alone (group Q) or prochlorperazine alone (group P). b, total quinine plasma levels. c, free quinine plasma levels. Bars are the percentage of a baseline value and 95% confidence interval determined after 2.5 hr of quinine infusion (groups QP and Q) or immediately before injection (group P). Note prolongation of the QT, interval in the group QP only (a) that is not explainable by changes in quinine levels (b and c).
six healthy volunteers. The QT, intervals length-DISCUSSION enec but even our highest recorded value (360 msec) was well below the upper limit of normal
The rationale for the use of reversing agents values (440 msec). Standard treatment with oral in malaria centers on similarities between mulquinine (650 mg per os every 8 hr) and tetra-tidrug resistance in P. falciparum infection and cycline (250 mg per os four times a day) was that in tumor cells, where resistance is mediated begun as soon as patients were able to tolerate by a transport protein product of the multidrugoral medication and produced clinical and par-resistance (mdrl) gene. 2 . 3 There is evidence both asitologic cures in every case.
for and against a role for mdr-like genes in re-
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WATT AND OTHERS sistant P. falciparum infection. 6. 7 The possible Prochlorperazine reversed quinine resistance in harmful effects of reversing agent therapy are of cultured falciparum parasites (Kyle D, Division concern in both malaria and neoplasia, but are of Experimental Therapeutics, Walter Reed Army difficult to assess in cancer patients. When cornInstitute of Research, Washington DC, unpubpared with individuals being treated for malaria, fished data), presumably by inhibition of the paroncology patients are generally older, are receivasite drug pump. Another possibility is that PC ing more toxic therapeutic agents, and have mul-potentiates quinine effects on cardiac cell memtiple medical problems.
branes. Quinine, like quinindine, is thought to The results of our study extend observations lengthen the duration of myocardial repolarizafrom in vitro and animal work, which suggest tion by influencing action potentials of cells in that reversing agent therapy may be unsafe.
6 -7 the cardiac conduction system,"' and has been Prochlorperazine clearly amplified the delays in shown to alter cell membrane electrical conducmyocardial repolarization that commonly ac-tivity. We measured a benign ECG effect of quinine by which ECG changes were potentiated by PC as a marker of potential toxicity, and observed cannot be stated with certainty. Quinine levels that quinine co-administered with PC prolonged did not increase after PC was injected (Figure the QT, interval. The theoretical concern that I b). Serum albumin levels were lower in the QP inhibition of P-glycoprotein might increase the group, but more biologically active unbound drug toxicity of drugs to normal tissues 2 2 is now supwas not the explanation for QT, interval length-ported by clinical evidence. Although methods ening in these patients. The QP group generally may be found for overcoming the toxicity of inhad lower, not higher, levels of free quinine (Fig-dividual reversing agents, 2 3 concerns about their ure I c); a, acid glycoprotein, not albumin, is the potentiation of the effects of co-administered major protein that binds quinine."' compounds should be investigated further. Such It is unlikely that PC by itself produced the concerns are timely since clinical trials of re-ECG changes. The QT, interval lengthening is a versing-agent therapy have now begun. 24 . 2 5 prominent toxic effect of some phenothiazines, particularly piperidine phenothiazines such as Acknowledgments: We thank Chartchai Palanand, thioridazine. " Piperazine phenothiazines, such Dokruk Thongkong, Samak Panyaprachum, Dr. Yongyuth Wongrungsub, and Dr. Pichit Soontornjirakarn as PC, are not noted for cardiac effects. The PC for helping with patient referrals, and Dr. N. J. White levels in plasma were not correlated with QTc for invaluable help with the study design. interval duration (Table 1) and PC given alone Financial support: This study was supported by the to healthy Thai controls shortened rather than United States Army Research and Development Cornlengthened myocardial repolarization (Figure la) . mand.
How did the administration of PC with quiDisclaimer: The opinions or assertions contained in nine lead to lengthening of the QT, interval? One this report are the private views of the authors and are possibility is that PC slows the extrusion of quinot to be construed as official or as reflecting the views nine from cardiac tissue, perhaps by inhibition of the United States Army. of an export pump such as P-glycoprotein.
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